Seeking Alpha

More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown:...

More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown: specialty pharmaceuticals +5% and 8.8% on a constant currency basis; medical devices +4% and +8.3%. Guidance: FY EPS $4.15-$4.19 vs. consensus of $4.17, revenue of $4.74B-$4.85B vs. $5.85B. Q3: EPS of $1.02-$1.04 vs. $1.06, revenue of $1.37B-$1.445B vs. $1.44B.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs